Optimisation of antihypertensive treatment by crossover rotation of four major classes
JEC Dickerson, AD Hingorani, MJ Ashby, CR Palmer… - The Lancet, 1999 - thelancet.com
Background Most comparisons of antihypertensive drugs aee undertaken in parallel groups.
We undertook a crossover rotation of the four main classes of antihypertensive drugs, in …
We undertook a crossover rotation of the four main classes of antihypertensive drugs, in …
Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients
J Chalmers, A Castaigne, T Morgan… - Journal of …, 2000 - journals.lww.com
Long-term efficacy of a new, fixed, very-low-dose angiotensi... : Journal of Hypertension
Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic …
Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic …
原发性高血压患者药物治疗依从性影响因素的分析
于黎， 朱大乔 - 解放军护理杂志, 2004 - cqvip.com
目的探讨影响高血压患者药物依从性的因素, 为提高患者服药依从性提供依据.
方法采用问卷式调查法, 对211 例高血压患者的一般状况和药物治疗依从性情况进行调查 …
方法采用问卷式调查法, 对211 例高血压患者的一般状况和药物治疗依从性情况进行调查 …
[图书][B] Diabetes and hypertension: evaluation and management
SI McFarlane, GL Bakris - 2012 - books.google.com
Hypertension and diabetes show a strong epidemiologic association. About 75% of adults
with diabetes have blood pressure levels= 130/80 mmHg or use antihypertensive …
with diabetes have blood pressure levels= 130/80 mmHg or use antihypertensive …
尼群地平和卡托普利协同降低去窦弓神经大鼠血压波动性的作用
王进， 王敏伟， 苏定冯 - 沈阳药科大学学报, 2007 - cqvip.com
目的研究联合应用尼群地平和卡托普利可能具有的协同降低去窦弓神经大鼠血压及血压波动性
的作用. 方法以去窦弓神经大鼠为模型分别测定单次给予尼群地平或卡托普利及尼群地平与卡托 …
的作用. 方法以去窦弓神经大鼠为模型分别测定单次给予尼群地平或卡托普利及尼群地平与卡托 …
Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension
G Cremonesi, L Cavalieri, I Cikes, J Dobovisek… - Advances in …, 2002 - Springer
Abstract This 12-week randomized, parallel-group, multicenter study compared fixed
combinations of delapril (D) 30 mg plus indapamide (I) 2.5 mg and fosinopril (F) 20 mg plus …
combinations of delapril (D) 30 mg plus indapamide (I) 2.5 mg and fosinopril (F) 20 mg plus …
Improving treatment regimen adherence in coronary heart disease by targeting patient types
RS Turpin, JB Simmons, JF Lew, CM Alexander… - Disease Management & …, 2004 - Springer
Patient adherence to a treatment plan is central to the control of coronary heart disease
(CHD) and in the prevention of complications; it is reported to be the single most important …
(CHD) and in the prevention of complications; it is reported to be the single most important …
The HEDIS® Performance NAVIGATOR for Controlling High Blood Pressure: A Resource to Assist Health Plans Improve Patient Adherence
R Turpin, K Jungkind, L Salvucci - Disease Management, 2003 - liebertpub.com
This article describes how the resources in the Health Plan Employer and Data Information
Set (HEDIS®; a registered trademark of the National Committee for Quality Assurance) …
Set (HEDIS®; a registered trademark of the National Committee for Quality Assurance) …
Tratamiento farmacológico combinado en el manejo de la hipertensión arterial crónica esencial
VG Galvañ, MJE Giner, MJF Giner, JR i Mas - Hipertensión y riesgo …, 2004 - Elsevier
A pesar de la demostrada eficacia del abundante arsenal farmacológico disponible hoy día
para el tratamiento de la hipertensión arterial crónica, las tasas de control siguen siendo …
para el tratamiento de la hipertensión arterial crónica, las tasas de control siguen siendo …
Y 型输液, 注射过滤两用头皮针的研制
葛玲侠， 丁丽丽， 张淑娟 - 解放军护理杂志, 2004 - cqvip.com
临床上已经应用的普通型头皮针及Y 型静脉留置针, 在输液过程中需要静脉推注药物时,
须先关闭输液器开关或反折靠近与头皮针连接处的输液管, 以防止液体漏出 …
须先关闭输液器开关或反折靠近与头皮针连接处的输液管, 以防止液体漏出 …